Stock Market & Financial Investment News

News Breaks February 4, 2013 09:02 EDT KERX Concerns about Keryx likely overblown, says JMP Securities JMP Securities indicates that it expects Keryx's Zerenex to be granted New Chemical Entity status, and the firm expects the company's patents to provide marketing exclusivity at least through 2022. The firm maintains an $8 price target and Outperform rating on Keryx. News For KERX From The Last 14 Days Check below for free stories on KERX the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 10, 2013 11:08 EDT KERX Keryx management to meet with Oppenheimer Subscribe for More Information May 7, 2013 16:47 EDT KERX Keryx reports Q1 EPS with items (3c), consensus (1c) Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.